| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |